SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-003644
Filing Date
2020-03-10
Accepted
2020-03-10 08:51:23
Documents
3
Period of Report
2020-03-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 44228
2 ex99-1.htm EX-99.1 24488
3 ex99-1_001.jpg GRAPHIC 12410
  Complete submission text file 0001493152-20-003644.txt   87272
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 20699991
SIC: 2834 Pharmaceutical Preparations